4
Changes in Ownership
Alzamend Neuro, Inc. Filed Acc 0001214659-25-010933
Director sold 69,137 shares at an average $2.95 ($203,821)
- Director acquired 143,429 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
AULT MILTON C III · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-23 | Conversion : show line 1 in the form | +143,429 | $2.32 | $332,755 | 151,689 | I |
| 2025-07-23 | Sale : show line 2 in the form | −59,516 | $2.95 | $175,584 | 92,173 | I |
| 2025-07-24 | Sale : show line 3 in the form | −9,621 | $2.93 | $28,237 | 82,552 | I |
| Open-market sales · 69,137 sh · avg $2.95 · $203,821 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-23 | Conversion : show line 4 in the form Series B Convertible Preferred Stock | −332.76 | $1,000.00 | $332,755 | 1,767.24 | I |
Loading xslF345X05/marketforms-70140.xml…